TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer (DEBIRITUX)
This study has been terminated.
(Terminated due to poor subject enrolment)
Sponsor:
Martin-Luther-Universität Halle-Wittenberg
Collaborator:
Biocompatibles UK Ltd
Information provided by (Responsible Party):
Dirk Arnold, Martin-Luther-Universität Halle-Wittenberg
ClinicalTrials.gov Identifier:
NCT01060423
First received: January 27, 2010
Last updated: June 27, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | September 2012 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |